Table 4.
Health resource use, stratified by primary tumor location (n = 640)
| Overall (n = 640)Follow‐up, yrs, mean (SD): 2.7 (2.8) | Pancreatic NET (n = 178)Follow‐up, yrs, mean (SD): 2.4 (2.7) | Midgut NET (n = 290)Follow‐up, yrs, mean (SD): 2.9 (2.9) | Other NET (n = 172)Follow‐up, yrs, mean (SD): 2.5 (2.6) | |||||
|---|---|---|---|---|---|---|---|---|
| Resource | User of resources, n (%) | HRU per PY, mean (SD) | User of resources, n (%) | HRU per PY, mean (SD) | User of resources, n (%) | HRU per PY, mean (SD) | User of resources, n (%) | HRU per PY, mean (SD) |
| Inpatient visit | 330 (51.6) | 5.6 (14.1) | 91 (51.1) | 8.6 (20.4) | 157 (54.1) | 4.5 (9.7) | 82 (47.7) | 4.2 (12.1) |
| Outpatient visit | 640 (100) | 25.7 (17.5) | 178 (100) | 29.3 (18.9) | 290 (100) | 23.2 (16.1) | 172 (100) | 26.3 (17.5) |
| Lab test | 606 (94.7) | 613.4 (631.2) | 164 (92.1) | 823 (916.4) | 280 (96.6) | 528.2 (479.8) | 162 (94.2) | 548.5 (431.7) |
| Diagnostic and imaging test | 444 (69.4) | 4.9 (11.3) | 121 (68) | 7.3 (18.4) | 206 (71) | 4.1 (7.7) | 117 (68) | 3.8 (5) |
| Radiology test | 591 (92.3) | 20.5 (23.3) | 164 (92.1) | 25.2 (24.9) | 271 (93.4) | 18.2 (25) | 156 (90.7) | 19.8 (17) |
| Transfusion | 236 (36.9) | 3.3 (8.2) | 67 (37.6) | 5.8 (13.7) | 115 (39.7) | 2.1 (4.1) | 54 (31.4) | 2.8 (3.8) |
Abbreviations: HRU, health resource use; NET, neuroendocrine tumor; PY, patient‐year.